Results 231 to 240 of about 3,310,854 (363)

Recent Developments in the Optical Control of Adrenergic Signaling

open access: yesMedicinal Research Reviews, EarlyView.
ABSTRACT Adrenoceptors (ARs) play a vital role in various physiological processes and are key therapeutic targets. The advent of optical control techniques, including optogenetics and photopharmacology, offers the potential to modulate AR signaling with precise temporal and spatial resolution. In this review, we summarize the latest advancements in the
Shuang Shi   +4 more
wiley   +1 more source

Population Pharmacokinetics and Exposure‐Response Relationship of Hemoporfin in Pediatric Patients With Port‐Wine Stain

open access: yesCPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Hemoporfin, a porphyrin derivative photosensitizer, has been approved for the treatment of port‐wine stain (PWS) in adults. However, its optimal dose for the pediatric population remains unclear. This study aimed to explore appropriate dosing for pediatric patients with PWS through population pharmacokinetics (PopPK) and exposure‐response (ER)
Rong Chen   +6 more
wiley   +1 more source

Diagnosis and Management of Skin Toxicities in Systemic Treatment of Genitourinary Cancers. [PDF]

open access: yesCancers (Basel)
Chowdhury D   +11 more
europepmc   +1 more source

THE APPLICATION PERSPECTIVES OF LAKE CLAY INFUSED WITH NATURAL ACTIVE AGENTS - ESSENTIAL OILS IN COSMETOLOGY AND DERMATOLOGY

open access: green
Rasma Tretjakova   +5 more
openalex   +2 more sources

Malignancies and immunoglobulin G4‐related disease

open access: yesRheumatology &Autoimmunity, EarlyView.
Immunoglobulin G4‐related disease (IgG4‐RD) is associated with increased cancer risk. Malignancies affect both IgG4‐RD involved organs, such as the lung, pancreas, bile duct, and prostate, and noninvolved organs, such as the gastrointestinal duct. B‐cell neoplasms constitute a proportion of the malignancies linked to this disease.
Jingna Li, Wen Zhang
wiley   +1 more source

Home - About - Disclaimer - Privacy